English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [5463]
News [12694]
Articles [177]
Editorials [5]
Conferences [249]
elearning [17]
New research raises awareness of the dangers of septic shock in blood cancer patients in USA
New research raises awareness of the dangers of septic shock in blood cancer patients in USA
Attacking cancer cells with photoactivatable proteinic nanobombs
Attacking cancer cells with photoactivatable proteinic nanobombs
New findings may contribute to better diagnosis and treatment of liver cancer
New findings may contribute to better diagnosis and treatment of liver cancer
Researchers identify signalling mechanisms in pancreatic cancer cells that could provide treatment targets
Researchers identify signalling mechanisms in pancreatic cancer cells that could provide treatment targets
Survival rate of adult patients with relapsed acute lymphoblastic leukaemia after haematopoietic cell transplantation has steadily increased over the past two decades
Survival rate of adult patients with relapsed acute lymphoblastic leukaemia after haematopoietic cell...
Researchers reveal how skin cells form a first line of defence against cancer
Researchers reveal how skin cells form a first line of defence against cancer
Researchers shine light on a rare form of kidney cancer
Researchers shine light on a rare form of kidney cancer
Protecting people with cancer from COVID-19: New recommendations from cancer guidelines organisation
Protecting people with cancer from COVID-19: New recommendations from cancer guidelines organisation
Depression screening improves care for patients with cancer
Depression screening improves care for patients with cancer
Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma
Relatlimab plus nivolumab improves progression-free survival in metastatic melanoma
<1...265266267268269...1270>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top